Search
for
Sort by
Research 61–90 of 1000+
- Endocrinology of the Aging Prostate: Current Concepts
- Insight into Recent Advances in Degrading Androgen Receptor for Castration-Resistant Prostate Cancer
- 412 DETECTION OF CIRCULATING PROSTATE CANCER CELLS BY MEANS OF AN ANTIBODY-CONJUGATED NANOPARTICULAR BIOSENSOR
- Sleep Problems are Associated with Development and Progression of Lower Urinary Tract Symptoms: Results from REDUCE
- Androgen receptor-mediated gene activation in prostate cancer cells
- Slow progress in prostate cancer
- Understanding the Epidemiology, Natural History, and Key Pathways Involved in Prostate Cancer
- Nonsteroidal Selective Androgen Receptors Modulators (SARMs): Designer Androgens with Flexible Structures Provide Clinical Promise
- Hydroxysteroid Dehydrogenase (17β -HSD3, 17β-HSD5, and 3α-HSD3) Inhibitors:Extragonadal Regulation of Intracellular Sex Steroid Hormone Levels
- Recent Advances in the Chemistry and Pharmacological Activity of New Steroidal Antiandrogens and 5α-Reductase Inhibitors
- 9 Role of 5α-reductase in health and disease
- Finasteride
- Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
- The preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Testosterone Hormone ; Clinical Indications, Dysregulation and Therapeutic methods
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Effects of pre- and post-pubertal dihydrotestosterone treatment on penile length in 5α-reductase type 2 deficiency
- Recent Advances in Drug Design and Drug Discovery for Androgen- Dependent Diseases
- Review Article: Practical Aspects of Testosterone Deficiency Syndrome in Clinical Urology
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- Effect of finasteride and/or terazosin on serum PSA: Results of VA cooperative study #359
- High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma
- The population dynamics of cancer: a Darwinian perspective
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- CAG Repeat Testing of Androgen Receptor Polymorphism: Is This Necessary for the Best Clinical Management of Hypogonadism?
- Does a male polycystic ovarian syndrome equivalent exist?
- Androgenetic alopecia as an early marker of benign prostatic hyperplasia
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Benign Prostatic Hyperplasia: A Disorder of Androgen Metabolism in the Male